Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Manufacturing and supply agreement signed for Genasense

Jan. 8, 2003

Pharmacokinetic, toxicity and efficacy data for LEraf-AON in animals

Jan. 7, 2003

HDAC inhibitor MS-275 active against pediatric solid tumors in vitro and in vivo

Jan. 7, 2003

Velcade enters phase II trial in colorectal cancer

Jan. 7, 2003

Cytogen regains rights to ex vivo prostate cancer immunotherapy

Jan. 7, 2003

Results reported for NBI-3001 in glioblastoma

Jan. 7, 2003

Phase I interim safety data reported for Reolysin in malignant glioma

Jan. 7, 2003

Azido-based photosensitizers covered by Mallinckrodt patent

Jan. 3, 2003

Potential antileukemia agents selected from series of arsonic acids

Jan. 3, 2003

Inhibition of tight junction function as a novel approach to breast cancer

Jan. 3, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...